AMPEL BioSolutions Company
AMPEL is a precision medicine company commercializing LDTs that predict disease status, molecular pathways, and best drug options.
.jpg)
Technology:
Data-driven Technologies
Industry:
Clinical Development, PharmTech
Headquarters:
Charlottesville, Virginia, United States
Founded Date:
2013-07-13
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
1
Total Funding:
12510000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2022-12-13
Last Funding Type:
Debt Financing
Register and Claim Ownership